ATTN: Psychedelic Drug Approved for First Clinical Trial by Drug Enforcement Administration

March 17, 2015

MAPS in the Media

Post navigation

Previous MAPS in the Media

Nature: Marijuana Gears Up for Production High in US Labs

Next MAPS in the Media

Huffington Post: DEA Approves Study Of Psychedelic Drug MDMA In Treatment Of Seriously Ill Patients

About
Our Work
Our Research
- MDMA
- Marijuana
- LSD
- Ibogaine
- Ayahuasca
News
Take Action

Newsletter Sign Up

Email

Δ

Facebook
Instagram
Twitter
YouTube
LinkedIn
Reddit

© 1986 - 2022 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved. Disclaimer | Privacy Policy.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117. For any donation related material please use this address: MAPS, P.O. Box 103004, Pasadena, CA 91189-3004
Proudly powered by WordPress. Hosted by Pressable.

Download our Integration Guide

Just enter your email in order to download our Integration Guide